{
    "2018-08-31": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Do the Risks in Marijuana Stocks Outweigh the Rewards?",
                "features": {
                    "keywords": [
                        "Risks",
                        "Marijuana Stocks",
                        "Outweigh",
                        "Rewards"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK's HIV Drug in Focus",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "Approval",
                        "NVS",
                        "ABBV",
                        "Cancer Drugs",
                        "MRK",
                        "HIV Drug"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK's HIV Drug in Focus",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "Approval",
                        "NVS",
                        "ABBV",
                        "Cancer Drugs",
                        "MRK",
                        "HIV Drug"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "4 Large Cap Pharma Stocks in Focus on Robust Cancer Pipeline",
                "features": {
                    "keywords": [
                        "Large Cap",
                        "Pharma Stocks",
                        "Focus",
                        "Robust",
                        "Cancer Pipeline"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}